What does "Paash" refer to in a medical context?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

"Paash" Does Not Appear to Be a Recognized Medical Term

I cannot identify "Paash" as a standard medical term, abbreviation, or acronym in the provided evidence or in general medical terminology. The evidence provided focuses entirely on pulmonary hypertension (PH) and pulmonary arterial hypertension (PAH), which may suggest a possible confusion or typographical error.

Possible Interpretations

If you meant "PAH" (Pulmonary Arterial Hypertension):

PAH is a specific clinical condition within Group 1 pulmonary hypertension, defined hemodynamically by right-heart catheterization as:

  • Mean pulmonary artery pressure ≥25 mmHg at rest (recently updated to >20 mmHg) 1
  • Pulmonary artery wedge pressure ≤15 mmHg 2
  • Pulmonary vascular resistance ≥3 Wood units 2

This represents pre-capillary pulmonary hypertension in the absence of other causes such as lung disease, chronic thromboembolic disease, or left heart disease 1.

Clinical Context

PAH includes multiple subtypes 1:

  • Idiopathic PAH (IPAH)
  • Heritable PAH (including BMPR2 mutations)
  • Drug and toxin-induced PAH
  • Associated PAH (connective tissue disease, HIV, portal hypertension, congenital heart disease, schistosomiasis, chronic hemolytic anemia)

Diagnostic Approach

If evaluating for PAH, the algorithm involves 1:

  • Transthoracic echocardiography for initial screening
  • Ventilation/perfusion scan to exclude chronic thromboembolic disease
  • Right heart catheterization for definitive diagnosis 1
  • Assessment of functional status and risk stratification

Clarification Needed

Please verify the exact term you are asking about. If this is a regional term, abbreviation from a specific medical system, or refers to something other than PAH, additional context would be necessary to provide accurate medical guidance.

Related Questions

For a welder who underwent an appendectomy, are work restrictions still required two weeks post‑operation, or can he return to unrestricted welding duties?
What is the appropriate general anesthesia plan for a healthy 55-year-old female undergoing tonsillectomy?
What is the English translation of the Portuguese term "folículo linfoide"?
What are the rules for responding only with verifiable sources, indicating whether the source was in effect as of November 2023, distinguishing guidelines, studies, and opinions, and stating "non lo so" if unsure?
What is the name of the surgical procedure to remove the gallbladder?
For a patient with hepatic contusion, possible pancreatic injury, and renal contusion who is on recent antiplatelet therapy, what monitoring strategy should be used, how should changes in risk be assessed, and after how many days post‑injury can the patient consider himself improving?
Why is domperidone contraindicated in patients with cardiac disease?
In an elderly patient with a recurrent furuncle in the groin, no other complaints, who has already been treated with ciprofloxacin (Floxapen) and amoxicillin‑clavulanate (Augmentin) and now presents a new lesion, what management steps, investigations, and appropriate medication should be undertaken?
When should a patient with hepatic and renal contusions be transitioned from subcutaneous low‑molecular‑weight heparin to an oral direct anticoagulant (NOAC/DOAC) and what factors determine the timing?
Can you provide an example endoscopic report for a 70‑year‑old female with a history of Roux‑en‑Y gastric bypass who now presents with cholangitis and has just undergone the first stage of an endoscopic ultrasound‑guided transgastric ERCP (EDGE) with successful placement of a 15 mm cautery‑enhanced Axios lumen‑apposing metal stent from the gastric remnant to the original gastric pouch?
In a trauma patient with hepatic and renal contusions who is currently receiving subcutaneous low‑molecular‑weight heparin, how does switching to apixaban affect the risk of intracranial hemorrhage?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.